Recreational and medical dispensaries in developed markets are pleasant, with highly knowledgeable staff and an element of novelty attached to their wide, rotating selection. Dispensary visits will remain industry-standard as long as large chain pharmacies do not introduce competing product lines and internet delivery remains unavailable. The industry has developed a sales model that is welcoming, informative, simple, and repeatable for new users.

According to Arcview Market Research, concentrates represented just 10% of sales in 2014 and as much as 27% in 2017. Concentrates will continue to gain market share and will rival flower as the dominant consumption modality as soon as 2022. Flower might eventually become the secondary mode of consumption, as looming federal legalization will inevitably demand a level of product assurance and FDA testability that concentrates can satisfy and flower cannot. Modern technology struggles to test chemical concentrations in flower due to its lack of uniform physiology.

Female Shoppers Driving Industry Growth

Two years of customer data show that DopeBoo’s online headshop is increasingly tended by women.

DopeBoo’s increasing vaporizer sales are largely driven by female buyers. DopeBoo customer data shows women are 2x more likely to purchase vaporizers for ingesting concentrates, over traditional devices for ingesting flower. If DopeBoo’s data can be extrapolated into societal trends, women are implicated in the significant jump in national concentrate sales.